Jeffrey R. Spencer

915 total citations
30 papers, 721 citations indexed

About

Jeffrey R. Spencer is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Jeffrey R. Spencer has authored 30 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Organic Chemistry and 11 papers in Hematology. Recurrent topics in Jeffrey R. Spencer's work include Chemical Synthesis and Analysis (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Mast cells and histamine (6 papers). Jeffrey R. Spencer is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Mast cells and histamine (6 papers). Jeffrey R. Spencer collaborates with scholars based in United States, Switzerland and New Zealand. Jeffrey R. Spencer's co-authors include B.A. Katz, Paul A. Sprengeler, Christine Luong, Richard L. Mackman, Murray Goodman, Erik Verner, James W. Janc, Darin A. Allen, Hon C. Hui and Kyle Elrod and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Journal of Molecular Biology.

In The Last Decade

Jeffrey R. Spencer

29 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey R. Spencer United States 16 326 315 135 109 79 30 721
Todd W. Rockway United States 20 387 1.2× 237 0.8× 182 1.3× 83 0.8× 159 2.0× 38 940
Julie A. Krueger United States 18 394 1.2× 237 0.8× 97 0.7× 140 1.3× 198 2.5× 31 906
Wolfgang von der Saal Germany 16 423 1.3× 357 1.1× 57 0.4× 228 2.1× 101 1.3× 35 959
Ana Negri Spain 18 649 2.0× 146 0.5× 75 0.6× 130 1.2× 119 1.5× 31 1.1k
Henry W. Pauls United States 17 390 1.2× 368 1.2× 51 0.4× 215 2.0× 58 0.7× 44 943
Edwin J. Iwanowicz United States 20 574 1.8× 560 1.8× 75 0.6× 60 0.6× 97 1.2× 43 1.0k
Michael N. Greco United States 18 432 1.3× 489 1.6× 61 0.5× 57 0.5× 157 2.0× 32 967
Mark E. Schnute United States 19 618 1.9× 715 2.3× 72 0.5× 32 0.3× 134 1.7× 25 1.4k
Dennis Powell United States 22 500 1.5× 813 2.6× 47 0.3× 122 1.1× 194 2.5× 50 1.3k
James B. Doherty United States 19 455 1.4× 646 2.1× 186 1.4× 52 0.5× 234 3.0× 36 1.1k

Countries citing papers authored by Jeffrey R. Spencer

Since Specialization
Citations

This map shows the geographic impact of Jeffrey R. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey R. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey R. Spencer more than expected).

Fields of papers citing papers by Jeffrey R. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey R. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey R. Spencer. The network helps show where Jeffrey R. Spencer may publish in the future.

Co-authorship network of co-authors of Jeffrey R. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey R. Spencer. A scholar is included among the top collaborators of Jeffrey R. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey R. Spencer. Jeffrey R. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Miller, James L., Dmitri Leonoudakis, Karen Lariosa‐Willingham, et al.. (2015). Discovery and Characterization of Nonpeptidyl Agonists of the Tissue-Protective Erythropoietin Receptor. Molecular Pharmacology. 88(2). 357–367. 15 indexed citations
3.
Punnonen, Juha, James L. Miller, Timothy J. Collier, & Jeffrey R. Spencer. (2015). Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease. Current Topics in Medicinal Chemistry. 15(10). 955–969. 13 indexed citations
4.
Gropen, Toby, Jeffrey R. Spencer, Nazli Janjua, et al.. (2014). Factors Related to the Sensitivity of Emergency Medical Service Impression of Stroke. Prehospital Emergency Care. 18(3). 387–392. 27 indexed citations
5.
Punnonen, Juha, Marcus O. Muench, & Jeffrey R. Spencer. (2008). Differential Effects of a Novel Non-Peptidic Thrombopoietin Mimetic on Proliferation and Differentiation of Human CD34+ Progenitor Cells. Blood. 112(11). 2888–2888. 2 indexed citations
6.
Drewe, John, Shailaja Kasibhatla, Ben Tseng, et al.. (2007). Discovery of 5-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-7-phenyl-(E)-2,3,6,7-tetrahydro-1,4-thiazepines as a new series of apoptosis inducers using a cell- and caspase-based HTS assay. Bioorganic & Medicinal Chemistry Letters. 17(17). 4987–4990. 15 indexed citations
7.
Sperandio, David, Vincent W.‐F. Tai, Julia Lohman, et al.. (2006). Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(15). 4085–4089. 9 indexed citations
8.
Lee, Chang-Sun, Weili Liu, Paul A. Sprengeler, et al.. (2006). Design of novel, potent, and selective human β-tryptase inhibitors based on α-keto-[1,2,4]-oxadiazoles. Bioorganic & Medicinal Chemistry Letters. 16(15). 4036–4040. 11 indexed citations
9.
Sprengeler, Paul A., Michael B. Shaghafi, Jeffrey R. Spencer, et al.. (2006). Discovery of novel hydroxy pyrazole based factor IXa inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(10). 2796–2799. 12 indexed citations
10.
Estevez, Alberto, et al.. (2006). Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G. Bioorganic & Medicinal Chemistry Letters. 16(12). 3180–3183. 51 indexed citations
11.
Spencer, Jeffrey R., Martin Sendzik, Jason Oeh, et al.. (2006). Evaluation of antitumor properties of novel saframycin analogs in vitro and in vivo. Bioorganic & Medicinal Chemistry Letters. 16(18). 4884–4888. 15 indexed citations
12.
Katz, B.A., Kyle Elrod, Erik Verner, et al.. (2003). Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors. Journal of Molecular Biology. 329(1). 93–120. 30 indexed citations
13.
Spencer, Jeffrey R., D. P. C. MCGEE, Darin A. Allen, et al.. (2002). 4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(15). 2023–2026. 22 indexed citations
14.
Sperandio, David, Anthony R. Gangloff, Joane Litvak, et al.. (2002). Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 12(21). 3129–3133. 29 indexed citations
15.
Katz, B.A., Kyle Elrod, Christine Luong, et al.. (2001). A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees. Journal of Molecular Biology. 307(5). 1451–1486. 61 indexed citations
16.
Katz, B.A., Paul A. Sprengeler, Christine Luong, et al.. (2001). Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chemistry & Biology. 8(11). 1107–1121. 51 indexed citations
17.
Verner, Erik, B.A. Katz, Jeffrey R. Spencer, et al.. (2001). Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode:  Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa. Journal of Medicinal Chemistry. 44(17). 2753–2771. 111 indexed citations
18.
Huang, Ziwei, et al.. (1993). Cyclic hexapeptide analogs of somatostatin containing bridge modifications. International journal of peptide & protein research. 42(4). 352–365. 24 indexed citations
19.
Spencer, Jeffrey R., et al.. (1993). Unusual peptide bond cleavage reactions during acidolytic deprotection reactions. The Journal of Organic Chemistry. 58(6). 1635–1638. 14 indexed citations
20.
Spencer, Jeffrey R., et al.. (1992). Comparative study of methods to couple hindered peptides. International journal of peptide & protein research. 40(3-4). 282–293. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Todd W. Rockway Breakdown of academic impact, for papers by Julie A. Krueger Breakdown of academic impact, for papers by Wolfgang von der Saal Breakdown of academic impact, for papers by Ana Negri Breakdown of academic impact, for papers by Henry W. Pauls Breakdown of academic impact, for papers by Edwin J. Iwanowicz Breakdown of academic impact, for papers by Michael N. Greco Breakdown of academic impact, for papers by Mark E. Schnute Breakdown of academic impact, for papers by Dennis Powell Breakdown of academic impact, for papers by James B. Doherty
Rankless by CCL
2026